Search
Eterna Therapeutics Inc
ERNAAdd to Watchlist
3.850USD
-0.110-2.78%
Market hours 09/22, 11:00（ET）
4.50MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-2.78%
5 Days
-9.84%
1 Month
-20.78%
6 Months
-42.96%
Year to Date
-87.17%
1 Year
-88.42%
Key Figures
3.970Open
3.850High
100.00Volume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
3.960Prev. Close
3.850Low
385.00Turnover
LossP/E Static
1.41P/B
0.00%Div Yield TTM
-145.98%ROA
15.88052wk High
0.00Volume Ratio
-44.55MNet Profit
1.17MShares
-172.0495EPS TTM
2.46Beta
-2514.66%ROE
3.35052wk Low
0.00%Amplitude
100.00%Gross Margin
4.50MMarket Cap
-2.61Reward/Risk
148.63%Risk Rate
More news coming soon, stay tuned...
Eterna Therapeutics Inc's Score
-0.13vs previous score
Forecast8.00
Financial Health6.52
Technical5.64
Valuation Dimensions7.65
Institutional Confidence3.00
Risk Assessment1.66
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Eterna Therapeutics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-3.40/-3.30
Revenue / Forecast
--/--
Eterna Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolERNA
Number of employees6
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Cherington (Charles) | 23.25% |
| Freebird Partners LP | 6.98% |
| Regolith Capital Investments LP | 6.03% |
| Halpern (John D) | 3.98% |
| Shareholder Types | Proportion |
|---|---|
| Individual Investor | 27.46% |
| Corporation | 14.33% |
| Investment Advisor | 1.83% |
| Hedge Fund | 0.17% |
Related Instruments
+0.59%
+0.05%
+0.20%
+0.31%
+1.63%
+0.30%
+4.27%
+1.61%
+0.51%
-0.95%
+1.87%
+0.02%
-0.56%
+0.63%
+0.14%
+1.33%
+5.64%
-1.61%
+0.61%
-1.11%Popular Instruments
51870.400
-171.600 (-0.33%)
30697.000
+224.300 (+0.74%)
7771.600
+11.500 (+0.15%)
14641.000
+47.000 (+0.32%)
67108.000
+586.000 (+0.88%)
6346.300
+17.500 (+0.28%)
90.469
-1.487 (-1.62%)
341.180
+2.200 (+0.65%)
229.490
+2.110 (+0.93%)
4355.520
+12.800 (+0.29%)
FAQs
What is the current price of Eterna Therapeutics Inc (ERNA)?
The current price of Eterna Therapeutics Inc (ERNA) is 3.96.
What is the symbol of Eterna Therapeutics Inc?
The ticker symbol of Eterna Therapeutics Inc is ERNA.
What is the 52-week high of Eterna Therapeutics Inc?
The 52-week high of Eterna Therapeutics Inc is 15.88.
What is the 52-week low of Eterna Therapeutics Inc?
The 52-week low of Eterna Therapeutics Inc is 3.35.
What is the market capitalization of Eterna Therapeutics Inc?
The market capitalization of Eterna Therapeutics Inc is 4.57M.
Is Eterna Therapeutics Inc (ERNA) currently rated as Buy, Hold, or Sell?
According to analysts, Eterna Therapeutics Inc (ERNA) has an overall rating of Buy, with a price target of 30.00.
What is the Earnings Per Share (EPS TTM) of Eterna Therapeutics Inc (ERNA)?
The Earnings Per Share (EPS TTM) of Eterna Therapeutics Inc (ERNA) is -172.05.